Effect of Liposomal Bupivacaine for Fascia Iliaca Compartment Block on Early Postoperative Recovery Quality in Elderly Patients Undergoing Total Hip Arthroplasty: A Retrospective Cohort Study
Authors:
- Zaibao WangZWZaibao Wang
- Chunliu LiCLChunliu Li
- Qing ShaoQSQing Shao
- Xiangru LiuXLXiangru Liu
- Jiawei XiaoJXJiawei Xiao
- Min XuMXMin Xu
- Sheng WangSWSheng Wang
- Keqiang HeKHKeqiang He
Open Access
- 1 May 2026
- journal article
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 20, 1-14
Abstract
This retrospective cohort study aimed to determine whether liposomal bupivacaine used in suprainguinal fascia iliaca compartment block (S-FICB) is superior to 0.33% ropivacaine in improving the quality of early postoperative recovery in elderly patients with hip fractures who underwent total hip arthroplasty (THA). Outcomes included: 15-item Quality of Recovery Scale (QoR-15); Numerical Rating Scale (NRS) for pain; Pittsburgh Sleep Quality Index (PSQI); Harris Hip Score; plus rescue analgesic use and hospital stay. It should be noted that the observed benefits are limited to the early postoperative period. A retrospective analysis was conducted on 200 elderly patients (aged 65–85 years) with hip fractures who underwent total hip arthroplasty (THA). Patients were divided into two groups based on the local anesthetic they received for S-FICB: the ropivacaine group (RG group, n = 100) or the liposomal bupivacaine group (LBG group, n = 100). QoR-15 and Harris scores were recorded preoperatively and on days 1, 3, 5 postoperatively. NRS and PSQI were recorded preoperatively and on days 1, 2, 3, 5. Rescue analgesic consumption and hospital stay were recorded. On postoperative day 1, QoR-15 was higher in LBG vs RG (113.25±3.825 vs 105.6±3.75, P=0.0004). NRS was lower in LBG within the first 48 postoperative hours (P < 0.05). PSQI was better in LBG on postoperative days 1 and 2 (P < 0.01). Harris score was higher in LBG on postoperative day 1 (P = 0.0007). Rescue analgesic use and postoperative hospital stay were lower in LBG (P < 0.05). Liposomal bupivacaine is superior to ropivacaine in the early postoperative recovery and analgesia of elderly THA patients. However, this advantage is primarily limited to the early postoperative period. Prospective validation is required given the retrospective design.Keywords
This publication has 47 references indexed in Scilit:
- Comparison between pericapsular nerve group (PENG) block with lateral femoral cutaneous nerve block and supra-inguinal fascia iliaca compartment block (S-FICB) for total hip arthroplasty: a randomized controlled trialJournal of Anesthesia, 2023
- The Efficacy and Safety of Periarticular Injection in Total Joint Arthroplasty: A Direct Meta-AnalysisThe Journal of Arthroplasty, 2022
- Efficacy of Liposomal Bupivacaine and Bupivacaine Hydrochloride vs Bupivacaine Hydrochloride Alone as a Periarticular Anesthetic for Patients Undergoing Knee ReplacementJAMA Surgery, 2022
- Complex Regional Pain Syndrome: A Comprehensive ReviewPain and Therapy, 2021
- Preoperative sleep quality and adverse pain outcomes after total hip arthroplastyEuropean journal of pain, 2021
- The 2018 Definition of Periprosthetic Hip and Knee Infection: An Evidence-Based and Validated CriteriaThe Journal of Arthroplasty, 2018
- Intraoperative Infiltration of Liposomal Bupivacaine vs Bupivacaine Hydrochloride for Pain Management in Primary Total Hip Arthroplasty: A Prospective Randomized TrialThe Journal of Arthroplasty, 2018
- Systemic Safety of Liposomal Bupivacaine in Simultaneous Bilateral Total Knee ArthroplastyThe Journal of Arthroplasty, 2018
- Periarticular Injections in Knee and Hip Arthroplasty: Where and What to InjectThe Journal of Arthroplasty, 2017
- A phase 3, randomized, placebo-controlled trial of DepoFoam® bupivacaine (extended-release bupivacaine local analgesic) in bunionectomyAdvances in Therapy, 2011